Pyrimidine Synthesis Inhibitor
18 drugs across 9 manufacturers|18 Generic,0 Brand
The Pyrimidine Synthesis Inhibitor class contains 18 NDCs from 9 manufacturers (18 generic, 0 brand), at an average NADAC of $0.31 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
18
18G / 0B
Manufacturers
9
Avg $0.3086/unit
Avg 7d Change
-1.67%
Across 16 drugs with changes
7d Activity
of 18 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
9 manufacturers producing drugs in this therapeutic class(1 pricing outlier)
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Accord Healthcare Inc. manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
Teriflunomide market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Pyrimidine Synthesis Inhibitor class?
The Pyrimidine Synthesis Inhibitor class contains 18 NDCs from 9 manufacturers — 18 generic and 0 brand products.
What is the average price of Pyrimidine Synthesis Inhibitor drugs?
The average NADAC for the Pyrimidine Synthesis Inhibitor class is $0.3086 per unit across 18 NDCs.
Which manufacturers make Pyrimidine Synthesis Inhibitor drugs?
9 manufacturers make drugs in the Pyrimidine Synthesis Inhibitor class. Ranked by number of NDCs, the largest are Accord Healthcare Inc. (2), Teva Pharmaceuticals USA Inc. (2), Camber Pharmaceuticals Inc. (2), Aurobindo Pharma Limited (2), Alembic Pharmaceuticals Inc. (2).
How has Pyrimidine Synthesis Inhibitor pricing changed recently?
Over the past 7 days, 8 NDCs in this class rose and 8 fell, with a class-wide average change of -1.7%.